WT1 (Wilms tumor 1) peptide immunotherapy for childhood rhabdomyosarcoma: a case report. - Wikidata - wikimedia - TriplyDB

WT1 (Wilms tumor 1) peptide immunotherapy for childhood rhabdomyosarcoma: a case report.

WT1 (Wilms tumor 1) peptide immunotherapy for childhood rhabdomyosarcoma: a case report.

http://www.wikidata.org/entity/Q51830253

about

Immunotherapy of Childhood Sarcomas Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials Prognostic significance of WT1 expression in soft tissue sarcoma.Immunotherapy targets in pediatric cancer.Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine.WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy.Cryoimmunology for malignant bone and soft-tissue tumors.A Novel DNA Vaccine Platform Enhances Neo-antigen-like T Cell Responses against WT1 to Break Tolerance and Induce Anti-tumor Immunity.WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma.Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma.Two distinct effector memory cell populations of WT1 (Wilms' tumor gene 1)-specific cytotoxic T lymphocytes in acute myeloid leukemia patients.Immunotherapy Targeting WT1: Designing a Protocol for WT1 Peptide-Based Cancer Vaccine.WT1 peptide vaccination in a CML patient: induction of effective cytotoxic T lymphocytes and significance of peptide administration interval.

P2860

Q26795369-86371AD9-D3E6-4DB2-87F5-6561F3B8D0FF Q27026836-1E184853-B484-4992-A319-1909589AB6A6 Q33965010-CED2FCB5-B53B-4B45-88DB-76EBC87F2D5A Q35971029-D3CF28F2-B384-45FE-8549-65600AD381E3 Q37591458-3496B328-4691-4D0C-9084-856B2B55B6C4 Q37731720-ABFD1B14-F585-4AC4-8C37-3510818C39B8 Q37852619-294821C8-8BD2-430F-AE08-C4AD193B75EF Q38714821-34749209-6448-4F1E-94E5-8EE621455A03 Q38826671-5FBAEC61-F1D8-4A5D-B8A4-E7C3F6B6C3AD Q39336282-1324DA95-63DF-4532-9D9F-B07EB9760249 Q50743741-DFB70C64-3CBA-4D7A-8357-DF7DF7405F5C Q51490182-5ED83A51-F1FA-454B-B450-DA7BF2311BFA Q53345813-030E7D51-9F61-417D-8488-915EE98A7321

P2860

WT1 (Wilms tumor 1) peptide immunotherapy for childhood rhabdomyosarcoma: a case report.

http://www.wikidata.org/entity/Q51830253

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

WT1 (Wilms tumor 1) peptide immunotherapy for childhood rhabdomyosarcoma: a case report.

@en

type

label

WT1 (Wilms tumor 1) peptide immunotherapy for childhood rhabdomyosarcoma: a case report.

@en

prefLabel

WT1 (Wilms tumor 1) peptide immunotherapy for childhood rhabdomyosarcoma: a case report.

@en

P1433

Q51830253-36BA6D98-9514-4588-AF5D-CC7FF8F32234

P1476

Q51830253-F899C201-2954-4CBE-ACA3-FF4967F3EB53

P2093

Q51830253-0A897143-75DA-4A53-9E53-B733BCB2EFBF

Q51830253-0FA0595A-17A2-4B77-BCB2-FFEB85176BB8

Q51830253-1977E42B-91FB-4B9E-B6A8-3890E989FE7F

Q51830253-1BEA62FD-9929-4C12-BDFD-AEBAEC22C420

Q51830253-26740564-E234-4407-8843-E5A73C8CC8BF

Q51830253-2B62EBDA-60D5-41DA-943B-AE32B7798116

Q51830253-82196CA1-3C72-4F61-ADD2-5857091A78CA

Q51830253-94F8B260-7917-4C78-BF6B-789026567174

Q51830253-9F2920FA-71EF-4B50-8E6C-524E9E191173

Q51830253-9F5B3E72-6EEF-40E1-9A81-23661D885D8F

P2860

Q51830253-39F1CBFE-685C-480B-8D5C-0F0D8D186CDF

Q51830253-4420BEF5-416D-4638-9041-4AC23657E8DD

Q51830253-8B8DA46B-A3C8-45E0-9231-B59DA4E8B99B

Q51830253-9C8C2C88-BA8B-4140-8A75-4F097CDAC964

Q51830253-B14CA439-59FC-429C-BB01-854AF18E1DE9

Q51830253-CC8AF74E-9131-4109-85E6-0B0A2962641D

Q51830253-EE5EF82C-453B-42FE-874C-5528F1566ADA

P304

Q51830253-95F7CE88-93EB-4018-A5AE-5120DF15D786

P31

Q51830253-07B5C160-889A-4A2E-B59B-CE254EB56BF8

P356

Q51830253-741AFC43-A7FB-4C4E-AEB7-02C3C4F54160

P433

Q51830253-1CFFC359-8A6E-4A8A-891A-3B3D01ADFA2E

P478

Q51830253-0E3E47AD-739A-4962-B34B-8E2A0889FC98

P577

Q51830253-43A065A4-E2AC-4E6C-AFA6-E5286ABD0DBE

P698

Q51830253-AAFA7238-CA22-40C2-AC99-6BC12439BBB2

P921

Q51830253-A40AF45C-71D0-4259-B407-0FFED07079C2

P356

08880010802435500

P1433

Pediatric Hematology and Oncology

P1476

WT1 (Wilms tumor 1) peptide immunotherapy for childhood rhabdomyosarcoma: a case report.

@en

P2093

Akihiro Tsuboi

http://www.w3.org/2001/XMLSchema#string

Akihiro Yoneda

http://www.w3.org/2001/XMLSchema#string

Ayako Murao

http://www.w3.org/2001/XMLSchema#string

Haruo Sugiyama

http://www.w3.org/2001/XMLSchema#string

Hideaki Ohta

http://www.w3.org/2001/XMLSchema#string

Katsuyuki Aozasa

http://www.w3.org/2001/XMLSchema#string

Keiichi Ozono

http://www.w3.org/2001/XMLSchema#string

Masahiro Fukuzawa

http://www.w3.org/2001/XMLSchema#string

Sachiko Takizawa

http://www.w3.org/2001/XMLSchema#string

Sadao Tokimasa

http://www.w3.org/2001/XMLSchema#string

P2860

PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.

Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.

Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV.

WT1 peptide-based immunotherapy for patients with lung cancer: report of two cases.

Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues.

WT1 peptide cancer vaccine for patients with hematopoietic malignancies and solid cancers.

P304

74-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08880010802435500

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19206012

http://www.w3.org/2001/XMLSchema#string

P921